Janet Dorling

Janet Dorling appears in our data through filings on CymaBay Therapeutics, Inc. shares, published by SEC (Form 4). The record holds 4 filings, for trades running from 10 November 2023 to 12 February 2024.

The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

On 14 February 2024 came the latest disclosure, an option exercise for €26k in CymaBay Therapeutics, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.